WallStreetZenWallStreetZen

NYSEMKT: NRXS
Neuraxis Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

NRXS past revenue growth

How has NRXS's revenue growth performed historically?
Company
-8.37%
Industry
10.82%
Market
18.14%
NRXS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
NRXS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

NRXS earnings and revenue history

Current Revenue
$2.5M
Current Earnings
-$14.6M
Current Profit Margin
-594.6%

NRXS Return on Equity

Current Company
N/A
Current Industry
10.5%
Current Market
188%

Be the first to know when NRXS announces earnings.

NRXS Return on Assets

Current Company
-1,203%
Current Industry
5.3%
NRXS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

NRXS Return on Capital Employed

Current Company
1,028.24%
Current Industry
8.3%
NRXS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NRXS vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
NRXS$2.46M-$14.08M-$14.63M+50.44%N/A
AXDX$12.06M-$49.77M-$61.62M+16.29%N/A
BSGM$18.00k-$28.39M-$29.05M-79.80%N/A
PAVM$2.45M-$60.35M-$66.27M+121.45%N/A
QTI$40.36k-$5.08M-$6.10M-66.76%N/A
View Top Medical Device Stocks

Neuraxis Earnings & Revenue FAQ

What were NRXS's earnings last quarter?

On Invalid Date, Neuraxis (NYSEMKT: NRXS) reported Q4 2023 earnings per share (EPS) of -$0.85, up 1,114.29% year over year. Total Neuraxis earnings for the quarter were -$5.31 million. In the same quarter last year, Neuraxis's earnings per share (EPS) was -$0.07.

If you're new to stock investing, here's how to buy Neuraxis stock.

What was NRXS's earnings growth in the past year?

As of Q2 2024, Neuraxis's earnings has grown year over year. Neuraxis's earnings in the past year totalled -$14.63 million.

What was NRXS's revenue last quarter?

On Invalid Date, Neuraxis (NYSEMKT: NRXS) reported Q4 2023 revenue of $531.46 thousand up 13.31% year over year. In the same quarter last year, Neuraxis's revenue was $613.08 thousand.

What was NRXS's revenue growth in the past year?

As of Q2 2024, Neuraxis's revenue has grown -8.37% year over year. This is 19.19 percentage points lower than the US Medical Devices industry revenue growth rate of 10.82%. Neuraxis's revenue in the past year totalled $2.46 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.